UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning

Journal of clinical oncology, 2015-07, Vol.33 (21), p.2392-2398

2015

Volltextzugriff (PDF)

Pediatric Phase I Trials in Oncology: An Analysis of Study Conduct Efficiency

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8431-8441

2005

Volltextzugriff (PDF)

Effects of Interleukin-12 on the Immune Response to a Multipeptide Vaccine for Resected Metastatic Melanoma

Journal of clinical oncology, 2001-09, Vol.19 (18), p.3836-3847

2001

Volltextzugriff (PDF)

Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer

Journal of clinical oncology, 2019-01, Vol.37 (1), p.33-43

2019

Volltextzugriff (PDF)

Randomized Phase II Study Comparing Thalidomide With Medroxyprogesterone Acetate in Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2006-02, Vol.24 (6), p.898-903

2006

Volltextzugriff (PDF)

MDR1 Gene Expression and Outcome in Osteosarcoma: A Prospective, Multicenter Study

Journal of clinical oncology, 2000-07, Vol.18 (14), p.2685-2694

2000

Volltextzugriff (PDF)

Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

Journal of clinical oncology, 2005-02, Vol.23 (4), p.741-750

2005

Volltextzugriff (PDF)

Randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition versus cabozantinib in metastatic soft tissue sarcoma

Journal of clinical oncology, 2023-06, Vol.41 (17_suppl), p.LBA11504-LBA11504

2023

Volltextzugriff (PDF)

Selection bias clouds apparent benefit of longer hormone duration

Journal of clinical oncology, 2010-02, Vol.28 (5), p.e79; author reply e80-e79

2010

Volltextzugriff (PDF)

Elimination of pelvic exams in a high-risk ovarian cancer screening program

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e13059-e13059

2016

Volltextzugriff (PDF)

Outcomes and prediction of lethal recurrence after transoral robotic surgery for HPV+ head and neck cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6047-6047

2021

Volltextzugriff (PDF)

Anti-CTLA-4 probody BMS-986249 alone or in combination with nivolumab in patients with advanced cancers: Initial phase I results

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3058-3058

2020

Volltextzugriff (PDF)

Examining screening behaviors at a high-risk ovarian cancer clinic

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e13047-e13047

2017

Volltextzugriff (PDF)

Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for locally advanced pancreatic cancer

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.TPS786-TPS786

2020

Volltextzugriff (PDF)

A phase I/II trial of palbociclib, pembrolizumab, and endocrine therapy for patients with HR+/HER2- locally advanced or metastatic breast cancer (MBC): Clinical outcomes and stool microbial profiling

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.1038-1038

2024

Volltextzugriff (PDF)

Effects of plant-based diet (PBD) and exercise therapy (Ex) on weight and body composition in patients with primary hormone receptor (HR) positive breast cancer: A phase 2 randomized controlled trial

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.548-548

2024

Volltextzugriff (PDF)

SU2C-SARC032: A phase II randomized controlled trial of neoadjuvant pembrolizumab with radiotherapy and adjuvant pembrolizumab for high-risk soft tissue sarcoma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS11588-TPS11588

2018

Volltextzugriff (PDF)

Radiation oncology program directors’ attitudes towards 27 discrete palliative care skills

Journal of clinical oncology, 2019-11, Vol.37 (31_suppl), p.62-62

2019

Volltextzugriff (PDF)

Comprehensive immune profiling unravels evolution of spatial distribution and immune repertoire in tumor microenvironment from primary to metastatic triple-negative breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1079-1079

2022

Volltextzugriff (PDF)

Depression, Correlates of Depression, and Receipt of Depression Care Among Low-Income Women With Breast or Gynecologic Cancer

Journal of clinical oncology, 2005-05, Vol.23 (13), p.3052-3060

2005

Volltextzugriff (PDF)

Development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term androgen deprivation therapy with radiotherapy in men with localized high-risk prostate cancer across multiple phase III NRG/RTOG trials

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5001-5001

2023

Volltextzugriff (PDF)

Phase 2, randomized, double-blind trial of EC-18 versus placebo to mitigate the development and time course of oral mucositis from concomitant chemoradiation for head and neck cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.12106-12106

2022

Volltextzugriff (PDF)

Racial Disparity of Epidermal Growth Factor Receptor Expression in Prostate Cancer

Journal of clinical oncology, 2004-12, Vol.22 (23), p.4725-4677

2004

Volltextzugriff (PDF)

The prognosic value of the downregulation of leukocyte cell–derived chemotaxin 2 gene of hepatocellular carcinoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10559-10559

2011

Volltextzugriff (PDF)

1 – 25 von 886

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Current Content Access

SpracheItalienisch

ThemaAnimals

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(886)
Mit Volltextzugriff
(866)

Publikationsform

Artikel
(886)

Sprache

Englisch
(886)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Oncology
(217)
Life Sciences & Biomedicine
(214)
Science & Technology
(214)
Humans
(207)
Female
(148)
Middle Aged
(140)
Male
(137)
Adult
(126)
Aged
(112)
Biological And Medical Sciences
(106)
Medical Sciences
(106)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(56)
Treatment Outcome
(55)
Tumors
(53)
Original Reports
(51)
Aged, 80 And Over
(37)
Adolescent
(34)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(34)
Survival Analysis
(34)
Pharmacology. Drug Treatments
(31)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
(2)

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning

Pediatric Phase I Trials in Oncology: An Analysis of Study Conduct Efficiency

Effects of Interleukin-12 on the Immune Response to a Multipeptide Vaccine for Resected Metastatic Melanoma

Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer

Randomized Phase II Study Comparing Thalidomide With Medroxyprogesterone Acetate in Patients With Metastatic Renal Cell Carcinoma

MDR1 Gene Expression and Outcome in Osteosarcoma: A Prospective, Multicenter Study

Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

Randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition versus cabozantinib in metastatic soft tissue sarcoma

Selection bias clouds apparent benefit of longer hormone duration

Elimination of pelvic exams in a high-risk ovarian cancer screening program

Outcomes and prediction of lethal recurrence after transoral robotic surgery for HPV+ head and neck cancer

Anti-CTLA-4 probody BMS-986249 alone or in combination with nivolumab in patients with advanced cancers: Initial phase I results

Examining screening behaviors at a high-risk ovarian cancer clinic

Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for locally advanced pancreatic cancer

A phase I/II trial of palbociclib, pembrolizumab, and endocrine therapy for patients with HR+/HER2- locally advanced or metastatic breast cancer (MBC): Clinical outcomes and stool microbial profiling

Effects of plant-based diet (PBD) and exercise therapy (Ex) on weight and body composition in patients with primary hormone receptor (HR) positive breast cancer: A phase 2 randomized controlled trial

SU2C-SARC032: A phase II randomized controlled trial of neoadjuvant pembrolizumab with radiotherapy and adjuvant pembrolizumab for high-risk soft tissue sarcoma

Radiation oncology program directors’ attitudes towards 27 discrete palliative care skills

Comprehensive immune profiling unravels evolution of spatial distribution and immune repertoire in tumor microenvironment from primary to metastatic triple-negative breast cancer

Depression, Correlates of Depression, and Receipt of Depression Care Among Low-Income Women With Breast or Gynecologic Cancer

Development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term androgen deprivation therapy with radiotherapy in men with localized high-risk prostate cancer across multiple phase III NRG/RTOG trials

Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study

Phase 2, randomized, double-blind trial of EC-18 versus placebo to mitigate the development and time course of oral mucositis from concomitant chemoradiation for head and neck cancer

Racial Disparity of Epidermal Growth Factor Receptor Expression in Prostate Cancer

The prognosic value of the downregulation of leukocyte cell–derived chemotaxin 2 gene of hepatocellular carcinoma

Aktive Filter

Suchergebnisse filtern